Newland Pharmaceutical Co., Ltd. (SHE:301277)

China · Delayed Price · Currency is CNY

11.40

-0.13 (-1.13%)

Apr 30, 2026, 4:00 PM EDT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceutical Intermediates	657.85M	719.43M	643.85M	621.21M	508.93M
Pharmaceutical Intermediates Growth	-8.56%	11.74%	3.64%	22.06%	17.50%
Other	14.53M	7.00M	-	-	-
Other Growth	107.39%	-	-	-	-
Unallocated Other	-	-	7.59M	6.15M	4.91M
Unallocated Other Growth	-	-	23.34%	25.30%	-
Total	672.38M	726.44M	651.44M	627.36M	513.84M
Total Growth	-7.44%	11.51%	3.84%	22.09%	18.64%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	668.43M	710.23M	641.16M	611.27M	500.11M
China Growth	-5.89%	10.77%	4.89%	22.23%	22.45%
Foreign	3.95M	16.21M	10.28M	16.10M	13.73M
Foreign Growth	-75.63%	57.71%	-36.15%	17.28%	-44.47%
Total	672.38M	726.44M	651.44M	627.36M	513.84M
Total Growth	-7.44%	11.51%	3.84%	22.09%	18.64%

Source: S&P Global Market Intelligence.